Not These Ovaries Joins Give Miami Day 2024: Help Us Fund Ovarian Cancer Research

When I was diagnosed with stage 3B ovarian cancer at 33, I discovered a startling reality in women’s healthcare: there were no FDA-approved treatments for my type of tumor. 

Even more concerning was learning that less than 20% of women with similar diagnoses respond to current treatments. This isn’t just a gap in medical care; it’s a clear signal that we need to do better for women’s health.

This year, Not These Ovaries participated in Give Miami Day, our community’s most impactful 24-hour giving event. The initiative came at a crucial moment for ovarian cancer research, particularly for younger women fighting this disease.

Real Progress, Real Impact

Since launching Not These Ovaries, we’ve already raised $1.8 million for one of the largest low-grade ovarian cancer research projects in the United States at Dana-Farber Cancer Institute. Now, Mount Sinai Medical Center in Miami Beach is preparing to launch another groundbreaking study focusing on understudied types of ovarian cancer that primarily affect younger women.

These research projects are lifelines for women who currently have limited options. When dealing with rare forms like low-grade serous ovarian cancer (LGSOC) and borderline ovarian tumors (BOT), many women face not only cancer itself but also life-changing consequences like infertility and treatment-induced early menopause.

The Power of Community Giving

The Miami Foundation‘s Give Miami Day demonstrated how community support can multiply impact. Thanks to our generous supporters, Not These Ovaries raised $9,520 during this year’s event. Through the event’s bonus pool, donations between $25 and $10,000 received additional matching funds, maximizing each gift’s impact.

At Not These Ovaries, we maintain a straightforward approach:

• 100% of donations go directly to research
• No administrative costs taken from public donations
• No fancy galas or confusing initiatives

Why This Research Matters

Women’s health research has historically been underfunded, particularly for conditions like ovarian cancer. The average survival rate after a low-grade serous ovarian cancer diagnosis is 9 years, and current treatment options are limited. This isn’t just a medical issue; it’s a wake-up call for how we prioritize women’s health research.

Your ongoing support helps:

• Fund innovative clinical trials
• Support Miami researchers focused on rare ovarian cancers
• Develop our ovarian cancer doctor directory for women to find and get the care they need
• Fund new treatments to give patients more options

The Spirit of Giving Continues

While Give Miami Day 2024 has concluded, our mission continues. Every contribution brings us closer to developing effective treatments for women facing ovarian cancer. Visit our Impact page to learn more about our ongoing work and how you can support breakthrough research happening right here in our community. Together, we can ensure that future generations of women have better options than those available today.